Retraction
RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine
Paper Information
Record ID:
42788
Journal:
Publication Date:
December 08, 2003
Retraction Date:
February 16, 2023
(2.8 years years ago)
Subjects:
Country:
šŗšø United StatesArticle Type:
Publisher:
Springer - Nature Publishing Group
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (230)
230
Total Citations4
Post-Retraction(1.7%)
226
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
2
Within 1 year
1
After 2+ years
869
Days since retraction (latest)
Ribonucleotide reductase (RNR) inhibitors as target-based weapon for future cancer drug development
Jaykumar Nagapara, Bimalkumar Patel, Bhargav Devliya et al. (5 authors)
Future Medicinal Chemistry
Published: Jul 2025
869 days after retraction
Adaptation to an acid microenvironment promotes pancreatic cancer organoid growth and drug resistance
Arnaud Stigliani, Renata Ialchina, Jiayi Yao et al. (10 authors)
Cell Reports
Published: Jun 2024
2 citations
2 citations
498 days after retraction
RRM2āmediated Wnt/Ī²ācatenin signaling pathway activation in lung adenocarcinoma: A potential prognostic biomarker
Yongjie Jiang, Xing Hu, Min Pang et al. (7 authors)
Oncology Letters
Open Access
Published: Aug 2023
9 citations
9 citations
175 days after retraction
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma
Cristina Di Giorgio, Rachele Bellini, Antonio Lupia et al. (19 authors)
Frontiers in Oncology
Open Access
Published: Mar 2023
11 citations
11 citations
26 days after retraction
Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver Cancer
Xin Yin, Kan Jiang, Ziyang Zhou et al. (7 authors)
Oxidative Medicine and Cellular Longevity
Open Access
Published: Jan 2023
5 citations
5 citations
27 days before retraction
Structure-based in silico investigation of antagonists of human ribonucleotide reductase from Annona muricata
Damilola A. Omoboyowa, Damilola S. Bodun, Jamiyu A. Saliu
Informatics in Medicine Unlocked
Open Access
Published: Jan 2023
18 citations
18 citations
46 days before retraction
Four Prognostic Related Genes Were Identified by Bio-Informatics Analysis as Key Genes in Lung Adenocarcinoma
Xinyu Sha, Houqiang Li, Gang Wang et al. (13 authors)
Unknown Journal
Published: Jan 2023
46 days before retraction
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma
Cristina Di Giorgio, Antonio Lupia, Silvia MarchianĆ² et al. (17 authors)
Cells
Open Access
Published: Nov 2022
12 citations
12 citations
105 days before retraction
Aberrant transcription factors in the cancers of the pancreas
Md. Hafiz Uddin, Md Najeeb Al-Hallak, Philip A. Philip et al. (6 authors)
Seminars in Cancer Biology
Published: Sep 2022
5 citations
5 citations
168 days before retraction
Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma
Lanqing Li, Xiaoqiang Wang, Haiying Xu et al. (5 authors)
Frontiers in Molecular Biosciences
Open Access
Published: Aug 2022
19 citations
19 citations
184 days before retraction
Mechanisms used by cancer cells to tolerate drug-induced replication stress
Hendrika A. Segeren, Bart Westendorp
Cancer Letters
Open Access
Published: Jun 2022
13 citations
13 citations
239 days before retraction
E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2
Qianfan Liu, Chunzhuo Song, Junjun Li et al. (8 authors)
Medical Oncology
Published: Jun 2022
13 citations
13 citations
243 days before retraction
Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present
Sarah Huff, Jordan M. Winter, Chris Dealwis
Biomolecules
Open Access
Published: Jun 2022
30 citations
30 citations
251 days before retraction
Role of ferroptosis in gastrointestinal tumors: From mechanisms to therapies
Chenli Si, Xiang Zhou, Jie Deng et al. (7 authors)
Cell Biology International
Published: Apr 2022
16 citations
16 citations
295 days before retraction
Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine
Ellen S. Smith, Eric Whitty, Byunghee Yoo et al. (6 authors)
Cancers
Open Access
Published: Mar 2022
50 citations
50 citations
332 days before retraction
Ribonucleotide reductase M2 subunit silencing suppresses tumorigenesis in pancreatic cancer via inactivation of PI3K/AKT/mTOR pathway
Jinlan Shan, Zhen Wang, Qiuping Mo et al. (9 authors)
Pancreatology
Published: Mar 2022
11 citations
11 citations
348 days before retraction
Ribonucleotide reductase subunit M2 promotes proliferation and epithelialāmesenchymal transition via the JAK2/STAT3 signaling pathway in retinoblastoma
Min Yang, Panpan Yao, Xuqiang Lang et al. (5 authors)
Bioengineered
Open Access
Published: Dec 2021
15 citations
15 citations
432 days before retraction
Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy
Sepideh Mirzaei, Mohammad Gholami, Hui Li Ang et al. (12 authors)
Cells
Open Access
Published: Nov 2021
47 citations
47 citations
444 days before retraction
miRNA profiling in adult T-cell leukemia lymphoma (ATLL), a systems virology study
Hadi Esmaeili Gouvarchinghaleh, Maryam Chenari, Mahdieh Farzanehpour et al. (7 authors)
Gene Reports
Published: Oct 2021
495 days before retraction
The High Expression of RRM2 Can Predict the Malignant Transformation of Endometriosis
Binkai Yang, Tian Wang, Na Li et al. (5 authors)
Advances in Therapy
Published: Aug 2021
15 citations
15 citations
544 days before retraction
A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer
Qian Liu, Lijuan Guo, Hongyan Qi et al. (14 authors)
Cell Death and Disease
Open Access
Published: Jul 2021
31 citations
31 citations
589 days before retraction
Derangement of cell cycle markers in peripheral blood mononuclear cells of asthmatic patients as a reliable biomarker for asthma control
Mahmood Yaseen Hachim, Noha Mousaad Elemam, Rakhee K. Ramakrishnan et al. (11 authors)
Scientific Reports
Open Access
Published: Jun 2021
16 citations
16 citations
622 days before retraction
Zebularine suppressed gemcitabine-induced senescence and improved the cellular and plasma pharmacokinetics of gemcitabine, augmented by liposomal co-delivery
Mingtan Tang, Lina Lozano Hernandez, Joy N. Reginald-Opara et al. (7 authors)
International Journal of Pharmaceutics
Published: Apr 2021
13 citations
13 citations
657 days before retraction
Identification of RRM2 as a Potential Biomarker for the Diagnosis and Prognosis of Rheumatoid Arthritis
Wu B, Yufeng Chen, Junlong Zhong et al. (10 authors)
Research Square (Research Square)
Open Access
Published: Apr 2021
660 days before retraction
pHāSensitive Polycations for siRNA Delivery: Effect of Asymmetric Structures of Tertiary Amine Groups
Qinping Yang, Yanliang Dong, Xuanyu Wang et al. (10 authors)
Macromolecular Bioscience
Published: Mar 2021
10 citations
10 citations
692 days before retraction
Imaging modalities delivery of RNAi therapeutics in cancer therapy and clinical applications
Loutfy H. Madkour
Journal of Radiology and Oncology
Open Access
Published: Mar 2021
714 days before retraction
Harnessing pH-Sensitive Polycation Vehicles for the Efficient siRNA Delivery
Changrong Wang, Xiaoxia Wang, Lili Du et al. (12 authors)
ACS Applied Materials & Interfaces
Published: Jan 2021
34 citations
34 citations
770 days before retraction
High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma
Chengyu Jin, Liang Du, Nuerlan Ahan et al. (6 authors)
Aging
Open Access
Published: Dec 2020
104 citations
104 citations
789 days before retraction
RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer
Yueyue Yang, Jiafei Lin, Susu Guo et al. (10 authors)
Cancer Cell International
Open Access
Published: Dec 2020
136 citations
136 citations
807 days before retraction
Inhibiting RRM2 to enhance the anticancer activity of chemotherapy
Yaqiong Zhan, Lushun Jiang, Xuehang Jin et al. (11 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Nov 2020
101 citations
101 citations
818 days before retraction
Small interfering RNA for cancer treatment: overcoming hurdles in delivery
Nitin B. Charbe, Nikhil D. Amnerkar, B. Ramesh et al. (16 authors)
Acta Pharmaceutica Sinica B
Open Access
Published: Oct 2020
179 citations
179 citations
856 days before retraction
ROS-Activatable siRNA-Engineered Polyplex for NIR-Triggered Synergistic Cancer Treatment
Jun Zhang, Yuhua Weng, Ziyang Cao et al. (11 authors)
ACS Applied Materials & Interfaces
Published: Jun 2020
58 citations
58 citations
966 days before retraction
Delivery of TSPAN1 siRNA by Novel Th17 Targeted Cationic Liposomes for Gastric Cancer Intervention
Zhengmao Lu, Tao Pang, Xiaoyi Yin et al. (7 authors)
Journal of Pharmaceutical Sciences
Published: Jun 2020
19 citations
19 citations
989 days before retraction
Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
Ying Z. Mazzu, Joshua Armenia, Subhiksha Nandakumar et al. (11 authors)
Molecular Oncology
Open Access
Published: May 2020
31 citations
31 citations
1013 days before retraction
A Humanized Yeast Phenomic Model of Deoxycytidine Kinase to Predict Genetic Buffering of Nucleoside Analog Cytotoxicity
Sean Santos, Mert Icyuz, Ilya Pound et al. (9 authors)
Genes
Open Access
Published: Sep 2019
5 citations
5 citations
1235 days before retraction
Chemogenomic study of gemcitabine using Saccharomyces cerevisiae as model cellāmolecular insights about chemoresistance
Lucas de Sousa Cavalcante, Tales A. Costa-Silva, Tiago AntƓnio de Souza et al. (5 authors)
Brazilian Journal of Microbiology
Open Access
Published: Sep 2019
2 citations
2 citations
1253 days before retraction
A humanized yeast phenomic model of deoxycytidine kinase to predict genetic buffering of nucleoside analog cytotoxicity
Sean Santos, Mert Icyuz, Ilya Pound et al. (9 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jul 2019
1 citation
1 citation
1305 days before retraction
Silencing RRM2 inhibits multiple myeloma byļæ½targeting the Wnt/Ī²ācatenin signaling pathway
Xia Liu, Jiamin Peng, Yayun Zhou et al. (5 authors)
Molecular Medicine Reports
Open Access
Published: Jul 2019
19 citations
19 citations
1324 days before retraction
Comprehensive analysis of competing endogenous RNA network and 3-mRNA signature predicting survival in papillary renal cell cancer
Xin Zhu, Jianyu Tan, Zongjian Liang et al. (4 authors)
Medicine
Open Access
Published: Jul 2019
7 citations
7 citations
1326 days before retraction
Knockdown of ribonucleotide reductase regulatory subunit M2 increases the drug sensitivity of chronic myeloid leukemia to imatinibābased therapy
Chunshui Liu, Yuying Li, Ruiping Hu et al. (5 authors)
Oncology Reports
Open Access
Published: Jun 2019
8 citations
8 citations
1346 days before retraction
Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value
Yangmei Zhou, Li Yang, Xiaoxi Zhang et al. (7 authors)
BioMed Research International
Open Access
Published: Apr 2019
59 citations
59 citations
1403 days before retraction
Role of hepatocyte nuclear factor 4 alpha in cell proliferation and gemcitabine resistance in pancreatic adenocarcinoma
Qiqing Sun, Wenyan Xu, Shunrong Ji et al. (10 authors)
Cancer Cell International
Open Access
Published: Mar 2019
29 citations
29 citations
1445 days before retraction
Adeno-associated virus 9-mediated RNA interference targeting SOCS3 alleviates diastolic heart failure in rats
Jie Gao, Yulin Guo, Yingqi Chen et al. (6 authors)
Gene
Published: Feb 2019
15 citations
15 citations
1466 days before retraction
siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin
Shuquan Zheng, Xiaoxia Wang, Yuhua Weng et al. (16 authors)
Molecular Therapy ā Nucleic Acids
Open Access
Published: Aug 2018
60 citations
60 citations
1653 days before retraction
An enhanced RRM2 siRNA delivery to rheumatoid arthritis fibroblast-like synoviocytes through a liposomeāprotamine-DNA-siRNA complex with cell permeable peptides
Xin Wang, Xueping Wang, Jin Sun et al. (4 authors)
International Journal of Molecular Medicine
Open Access
Published: Aug 2018
19 citations
19 citations
1653 days before retraction
Nano-Diamino-Tetrac (NDAT) Enhances Resveratrol-Induced Antiproliferation by Action on the RRM2 Pathway in Colorectal Cancers
AndrĆ© WendindondĆ© Nana, SzuāYuan Wu, YuāChen S. H. Yang et al. (18 authors)
Hormones and Cancer
Open Access
Published: Jul 2018
26 citations
26 citations
1672 days before retraction
The study of relationships between pKa value and siRNA delivery efficiency based on tri-block copolymers
Lili Du, Changrong Wang, Lingwei Meng et al. (12 authors)
Biomaterials
Open Access
Published: May 2018
51 citations
51 citations
1724 days before retraction
The promoted delivery of RRM2 siRNA to vascular smooth muscle cells through liposome-polycation-DNA complex conjugated with cell penetrating peptides
Yueting Wu, Jin Sun, Anjie Li et al. (4 authors)
Biomedicine & Pharmacotherapy
Published: Apr 2018
19 citations
19 citations
1758 days before retraction
Ribonucleotide reductase subunit M2B deficiency leads to mitochondrial permeability transition pore opening and is associated with aggressive clinicopathologic manifestations of breast cancer.
Lijun Xue, Xiyong Liu, Qinchuan Wang et al. (11 authors)
PubMed
Published: Jan 2018
8 citations
8 citations
1872 days before retraction
Precision design of nanomedicines to restore gemcitabine chemosensitivity for personalized pancreatic ductal adenocarcinoma treatment
Xiao Zhao, Xiuchao Wang, Wei Sun et al. (17 authors)
Biomaterials
Published: Dec 2017
31 citations
31 citations
1884 days before retraction
Quick Stats
Total Citations:
230
Years Since Retraction:
2.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025